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Dear Colleague,
We would like to welcome you to Ophthalmology
and Therapy, an international, web-based, open
access journal whose prime target is the therapy
of ocular disease.
Our aim, as Editors-in-Chief, is to ensure
rapid, peer-reviewed publication of original
articles on preclinical and clinical research
topics, in addition to reviews, case reports,
and short communications. Ophthalmology
and Therapy is interested in discovery, drug
development, and medical and surgical therapies
and devices.
Areas of focus include, but are not limited to,
ocular inflammation and infection, ocular
surgery (including cataract, keratorefractive,
glaucoma, vitreoretinal, and keratoplasty), and
also dry eye, ocular allergy, and conjunctivitis.
Other areas are medical retina, including
diabetic retinopathy, macular degeneration,
and macular edema. There is a special interest
in new devices and novel drugs and therapies.
The journal is also keen to publish research
concerning prevention and management as
well as the results of clinical trials and studies
of public health, pharmacoeconomic, diagnostic,
and general educational interest.
As an electronic publication, Ophthalmology
and Therapy has many advantages over
traditional publishing. We aim to complete
reviews within 2 weeks of receipt of an article,
and to publish online within 4 weeks from the
time of acceptance. Article length and number
of illustrations is not a constraint. Also, videos
and animations can be included and there is the
opportunity to set up interactive case studies. In
order to reach as wide an audience as possible,
each article includes a key summary slide, and it
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is possible to add a more extensive summary in
the form of a PowerPoint presentation with up
to 11 slides.
Other attractive features are also of interest.
Ophthalmology and Therapy publishes
supplements and special issues, in any
language. These may include sponsored
meeting proceedings, roundtable discussions,
workshop reports, case series, and so on, with all
articles subject to peer review. Details of page
charges and other aspects of the submission and
publication process can be found at http://
www.ophthalmology-open.com.
We think that you will enjoy reading
Ophthalmology and Therapy and enthusiastically
encourage you to contribute.
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